Blezer E - Search Results

1

Modelling of multiple sclerosis: lessons learned in a non-human primate.

't Hart BA, Laman JD, Bauer J, Blezer E, van Kooyk Y, Hintzen RQ. 't Hart BA, et al. Among authors: blezer e. Lancet Neurol. 2004 Oct;3(10):588-97. doi: 10.1016/S1474-4422(04)00879-8. Lancet Neurol. 2004. PMID: 15380155 Review.

2

Prevention of experimental autoimmune encephalomyelitis in the common marmoset (Callithrix jacchus) using a chimeric antagonist monoclonal antibody against human CD40 is associated with altered B cell responses.

Boon L, Brok HP, Bauer J, Ortiz-Buijsse A, Schellekens MM, Ramdien-Murli S, Blezer E, van Meurs M, Ceuppens J, de Boer M, 't Hart BA, Laman JD. Boon L, et al. Among authors: blezer e. J Immunol. 2001 Sep 1;167(5):2942-9. doi: 10.4049/jimmunol.167.5.2942. J Immunol. 2001. PMID: 11509643

3

Non-human primate models of multiple sclerosis.

Brok HP, Bauer J, Jonker M, Blezer E, Amor S, Bontrop RE, Laman JD, 't Hart BA. Brok HP, et al. Among authors: blezer e. Immunol Rev. 2001 Oct;183:173-85. doi: 10.1034/j.1600-065x.2001.1830114.x. Immunol Rev. 2001. PMID: 11782256 Review.

4

Prevention of experimental autoimmune encephalomyelitis in common marmosets using an anti-IL-12p40 monoclonal antibody.

Brok HP, van Meurs M, Blezer E, Schantz A, Peritt D, Treacy G, Laman JD, Bauer J, 't Hart BA. Brok HP, et al. Among authors: blezer e. J Immunol. 2002 Dec 1;169(11):6554-63. doi: 10.4049/jimmunol.169.11.6554. J Immunol. 2002. PMID: 12444167

5

Non-invasive measurement of brain damage in a primate model of multiple sclerosis.

't Hart BA, Vogels J, Bauer J, Brok HP, Blezer E. 't Hart BA, et al. Among authors: blezer e. Trends Mol Med. 2004 Feb;10(2):85-91. doi: 10.1016/j.molmed.2003.12.008. Trends Mol Med. 2004. PMID: 15102362 Review.

6

Treatment with chimeric anti-human CD40 antibody suppresses MRI-detectable inflammation and enlargement of pre-existing brain lesions in common marmosets affected by MOG-induced EAE.

't Hart BA, Blezer EL, Brok HP, Boon L, de Boer M, Bauer J, Laman JD. 't Hart BA, et al. J Neuroimmunol. 2005 Jun;163(1-2):31-9. doi: 10.1016/j.jneuroim.2005.02.005. Epub 2005 Apr 9. J Neuroimmunol. 2005. PMID: 15885306

7

Suppression of ongoing disease in a nonhuman primate model of multiple sclerosis by a human-anti-human IL-12p40 antibody.

't Hart BA, Brok HP, Remarque E, Benson J, Treacy G, Amor S, Hintzen RQ, Laman JD, Bauer J, Blezer EL. 't Hart BA, et al. Among authors: blezer el. J Immunol. 2005 Oct 1;175(7):4761-8. doi: 10.4049/jimmunol.175.7.4761. J Immunol. 2005. PMID: 16177124

8

MRI-guided immunotherapy development for multiple sclerosis in a primate.

't Hart BA, Smith P, Amor S, Strijkers GJ, Blezer EL. 't Hart BA, et al. Drug Discov Today. 2006 Jan;11(1-2):58-66. doi: 10.1016/S1359-6446(05)03673-1. Drug Discov Today. 2006. PMID: 16478692 Review.

9

Quantitative MRI-pathology correlations of brain white matter lesions developing in a non-human primate model of multiple sclerosis.

Blezer EL, Bauer J, Brok HP, Nicolay K, 't Hart BA. Blezer EL, et al. NMR Biomed. 2007 Apr;20(2):90-103. doi: 10.1002/nbm.1085. NMR Biomed. 2007. PMID: 16948176

10

Fast progression of recombinant human myelin/oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis in marmosets is associated with the activation of MOG34-56-specific cytotoxic T cells.

Kap YS, Smith P, Jagessar SA, Remarque E, Blezer E, Strijkers GJ, Laman JD, Hintzen RQ, Bauer J, Brok HP, 't Hart BA. Kap YS, et al. Among authors: blezer e. J Immunol. 2008 Feb 1;180(3):1326-37. doi: 10.4049/jimmunol.180.3.1326. J Immunol. 2008. PMID: 18209026

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters